Mymetics Appoints Grant Pickering CEO and Christopher Henney Chairman
Epalinges, Switzerland, 6 April 2012
Mymetics Corporation, a leader in the development of mucosal and virosomal-based vaccines for infectious diseases, announced today the appointment of Grant E. Pickering as President and Chief Executive Officer of Mymetics Corporation and the election of Dr. Christopher S. Henney as Chairman of the Board of Directors. Mymetics further announced the appointments of Ulrich Burkhard and Mr. Pickering to its Board of Directors. These changes are made in connection with the efforts of Mymetics to obtain additional financing and to advance the development of its vaccine platform.
|Media Name||Media Type||Description||Download|
|Mymetics PR 4-10-12 - Changes BoD and CEO||Download|